Rondo Therapeutics is a therapeutic antibody discovery and development that creates novel bispecific antibodies that activate the immune system to fight cancer. The company was founded in 2021 and is headquartered in Hayward, California.

Biotechnology

Health Care

Rondo Therapeutics

Rondo Therapeutics' headquarters in Hayward, CA, United States

Shelley Force Aldred

Jennifer Isacoff McNealey

Thomas Manley

Nathan Trinklein

Katherine Harris

The Research and Development team at Rondo Therapeutics is responsible for discovering and developing novel bispecific antibodies to enhance the immune system's ability to fight cancer. This team conducts preclinical studies, translates biological discoveries into therapeutic candidates, and manages early-stage research projects to advance the company’s pipeline of innovative cancer treatments.

Research and Development

The Leadership Team at Rondo Therapeutics, comprising the President, CSO, CEO & Co-founder, and Chief Development Officer (CDO), is responsible for setting the strategic direction, making high-level decisions, overseeing research and development activities, and ensuring the progress of therapeutic antibody programs aimed at activating the immune system to fight cancer. They guide the company towards achieving its scientific, operational, and financial goals.

Leadership Team

This department focuses on driving business growth and managing operational processes to support development initiatives.

Business Development Operations

This department provides strategic direction and governance for the organization.

Rondo Therapeutics

Org chart

Teams

Research and Development

Leadership Team

Business Development Operations

Executive Leadership

Offices

Rondo Therapeutics

Org chart

Teams

Research and Development

Leadership Team

Business Development Operations

Executive Leadership

Offices

Related companies